Detalhe da pesquisa
1.
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System.
Mol Ther
; 28(9): 1974-1986, 2020 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32526203
2.
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia.
Mol Ther
; 25(8): 1933-1945, 2017 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28479045
3.
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(12): 2070-2078, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28712935
4.
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia.
J Autoimmun
; 85: 141-152, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843422
5.
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories.
Cytotherapy
; 18(4): 481-6, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26971677
6.
Donor-derived CD19-targeted T cells in allogeneic transplants.
Curr Opin Hematol
; 22(6): 497-502, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26390165
7.
Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.
Biol Blood Marrow Transplant
; 20(3): 375-81, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24321746
8.
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia.
Br J Haematol
; 182(6): 939-943, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832950
9.
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia.
Br J Haematol
; 182(3): 434-436, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28573703
10.
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor.
Br J Haematol
; 161(3): 389-401, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23432359
11.
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor.
Blood
; 117(18): 4736-45, 2011 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21406718
12.
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis.
Biologicals
; 41(6): 439-45, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24135082
13.
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia.
Leuk Lymphoma
; 63(7): 1566-1579, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35259043
14.
Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia.
Cytotherapy
; 13(9): 1128-39, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21745159
15.
GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.
J Cell Mol Med
; 14(6B): 1619-34, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19627397
16.
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.
Biol Blood Marrow Transplant
; 16(9): 1293-301, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20350611
17.
Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors.
Haematologica
; 95(12): 2144-52, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20713459
18.
Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells.
J Biomed Biotechnol
; 2010: 234540, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20617141
19.
Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.
J Clin Invest
; 130(11): 6021-6033, 2020 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780725
20.
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression.
Mol Cancer
; 8: 106, 2009 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19922650